Escalon Medical Statistics
Total Valuation
Escalon Medical has a market cap or net worth of 1.40 million. The enterprise value is 1.85 million.
Market Cap | 1.40M |
Enterprise Value | 1.85M |
Important Dates
The last earnings date was Thursday, February 13, 2025.
Earnings Date | Feb 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Escalon Medical has 7.42 million shares outstanding. The number of shares has decreased by -20.76% in one year.
Current Share Class | n/a |
Shares Outstanding | 7.42M |
Shares Change (YoY) | -20.76% |
Shares Change (QoQ) | +89.90% |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | n/a |
Float | 7.27M |
Valuation Ratios
The trailing PE ratio is 30.71.
PE Ratio | 30.71 |
Forward PE | n/a |
PS Ratio | 0.11 |
PB Ratio | 1.01 |
P/TBV Ratio | 1.04 |
P/FCF Ratio | 8.24 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.12, with an EV/FCF ratio of 10.92.
EV / Earnings | 40.66 |
EV / Sales | 0.15 |
EV / EBITDA | 3.12 |
EV / EBIT | 8.79 |
EV / FCF | 10.92 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.16.
Current Ratio | 1.95 |
Quick Ratio | 0.96 |
Debt / Equity | 0.16 |
Debt / EBITDA | 0.55 |
Debt / FCF | 1.94 |
Interest Coverage | 10.76 |
Financial Efficiency
Return on equity (ROE) is 9.64% and return on invested capital (ROIC) is 5.38%.
Return on Equity (ROE) | 9.64% |
Return on Assets (ROA) | 2.86% |
Return on Invested Capital (ROIC) | 5.38% |
Return on Capital Employed (ROCE) | 9.26% |
Revenue Per Employee | 304,229 |
Profits Per Employee | 1,138 |
Employee Count | 40 |
Asset Turnover | 2.65 |
Inventory Turnover | 4.35 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.09% in the last 52 weeks. The beta is -0.29, so Escalon Medical's price volatility has been lower than the market average.
Beta (5Y) | -0.29 |
52-Week Price Change | -9.09% |
50-Day Moving Average | 0.15 |
200-Day Moving Average | 0.15 |
Relative Strength Index (RSI) | 87.62 |
Average Volume (20 Days) | 3,358 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, Escalon Medical had revenue of 12.17 million and earned 45,526 in profits. Earnings per share was 0.01.
Revenue | 12.17M |
Gross Profit | 5.38M |
Operating Income | 210,644 |
Pretax Income | 186,061 |
Net Income | 45,526 |
EBITDA | 253,958 |
EBIT | 210,644 |
Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 520,584 in cash and 329,105 in debt, giving a net cash position of 191,479 or 0.03 per share.
Cash & Cash Equivalents | 520,584 |
Total Debt | 329,105 |
Net Cash | 191,479 |
Net Cash Per Share | 0.03 |
Equity (Book Value) | 2.02M |
Book Value Per Share | 0.19 |
Working Capital | 2.09M |
Cash Flow
In the last 12 months, operating cash flow was 169,589 and capital expenditures 1, giving a free cash flow of 169,590.
Operating Cash Flow | 169,589 |
Capital Expenditures | 1 |
Free Cash Flow | 169,590 |
FCF Per Share | 0.02 |
Margins
Gross margin is 44.18%, with operating and profit margins of 1.73% and 1.53%.
Gross Margin | 44.18% |
Operating Margin | 1.73% |
Pretax Margin | 1.53% |
Profit Margin | 1.53% |
EBITDA Margin | 2.09% |
EBIT Margin | 1.73% |
FCF Margin | 1.39% |
Dividends & Yields
Escalon Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 20.76% |
Shareholder Yield | 20.76% |
Earnings Yield | 3.26% |
FCF Yield | 12.13% |
Stock Splits
The last stock split was on November 24, 1997. It was a reverse split with a ratio of 0.25.
Last Split Date | Nov 24, 1997 |
Split Type | Reverse |
Split Ratio | 0.25 |
Scores
Escalon Medical has an Altman Z-Score of -17.58. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -17.58 |
Piotroski F-Score | n/a |